Menu
GeneBe

9-34645848-AT-A

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2

The ENST00000605275.1(GALT):n.209-809del variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0093 ( 19 hom., cov: 0)

Consequence

GALT
ENST00000605275.1 intron, non_coding_transcript

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.901
Variant links:
Genes affected
GALT (HGNC:4135): (galactose-1-phosphate uridylyltransferase) Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP6
Variant 9-34645848-AT-A is Benign according to our data. Variant chr9-34645848-AT-A is described in ClinVar as [Benign]. Clinvar id is 1331425.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00933 (1172/125588) while in subpopulation AFR AF= 0.0301 (965/32036). AF 95% confidence interval is 0.0285. There are 19 homozygotes in gnomad4. There are 562 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 19 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GALTENST00000605275.1 linkuse as main transcriptn.209-809del intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00930
AC:
1168
AN:
125610
Hom.:
19
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0301
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00484
Gnomad ASJ
AF:
0.000310
Gnomad EAS
AF:
0.00118
Gnomad SAS
AF:
0.000816
Gnomad FIN
AF:
0.00872
Gnomad MID
AF:
0.0116
Gnomad NFE
AF:
0.00112
Gnomad OTH
AF:
0.00708
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00933
AC:
1172
AN:
125588
Hom.:
19
Cov.:
0
AF XY:
0.00944
AC XY:
562
AN XY:
59534
show subpopulations
Gnomad4 AFR
AF:
0.0301
Gnomad4 AMR
AF:
0.00491
Gnomad4 ASJ
AF:
0.000310
Gnomad4 EAS
AF:
0.00118
Gnomad4 SAS
AF:
0.000821
Gnomad4 FIN
AF:
0.00872
Gnomad4 NFE
AF:
0.00112
Gnomad4 OTH
AF:
0.00821

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpDec 16, 2021Variant summary: GALT c.-837delT is located in the untranscribed region upstream of the GALT gene region. The variant allele was found at a frequency of 0.0094 in 124506 control chromosomes, predominantly at a frequency of 0.03 within the African or African-American subpopulation in the gnomAD database, including 19 homozygotes. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 10-fold of the estimated maximal expected allele frequency for a pathogenic variant in GALT causing Galactosemia phenotype (0.0029), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.-837delT in individuals affected with Galactosemia and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs549043849; hg19: chr9-34645845; API